Results 121 to 130 of about 10,075 (184)

Monitoring of adaptive immune responses in healthcare workers who received a Coronavirus disease 2019 vaccine booster dose

Health Science Reports
Background and Aims Coronavirus disease 2019 (COVID‐19) has become a global pandemic and led to increased mortality and morbidity. Vaccines against the etiologic agent; severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) were approved for ...
Chompunuch Klinmalai, Supanart Srisala, Thiantip Sahakijpicharn, Nopporn Apiwattanakul   +3 more
doaj   +1 more source

Humoral anti-SARS-CoV-2 immune response for different strains after Sinovac-CoronaVac and Oxford/AstraZeneca (ChAdOx1-S) full vaccination on a healthcare population in Brazil

Revista Uningá
COVID-19, caused by the SARS-CoV-2 virus, is a global respiratory syndrome with high mortality rates. Vaccination is currently the only proven method to prevent the disease, although the role of lab data in assessing efficacy remains uncertain.
Maicon Jeferson Silva de Oliveira, Beatriz Birelli do Nascimento, Fernanda de Assis Oliveira, Mahelly Bueno de Almeida, Márcio Rodrigues, Flavia Cristina Cardoso Carvalho, Éric Diego Barioni, Rodrigo Azevedo Loiola, Rômulo Tadeu Dias de Oliveira, Gustavo Henrique Oliveira da Rocha   +9 more
doaj   +1 more source

Myocardial Infarction after ChAdOx1 nCoV-19 in a Young Male

Journal of Emergencies, Trauma, and Shock, 2022
V V. S. S. Sagar, Anil Wanjari, Sunil Kumar, Sourya Acharya   +3 more
openaire   +3 more sources

Erythrodermic psoriasis following ChAdOx1 nCOV-19 vaccination

Dermatologica Sinica, 2022
Pei-Tzu Lin, Ching-Chi Chi
openaire   +2 more sources

Guillain-Barré Syndrome Post COVID-19 Vaccination with ChAdOx1 nCoV-19 Vaccine: A Colombian Case Report. [PDF]

Case Rep Infect Dis, 2023
Hurtado IC, Vallejo-Serna R, Hurtado-Zapata JS, Misnaza SP.   +3 more
europepmc   +1 more source

Depression following ChAdOx1-S/nCoV-19 vaccine

The European Journal of Psychiatry, 2022
openaire   +2 more sources

Safety and humoral immunogenicity of the ChAdOx1 nCoV-19 vaccine administered as a fourth dose booster following two doses of ChAdOx1 nCoV-19 and a third dose of BNT162b2 (COV009) : a prospective cohort study

Objectives: evaluation of the safety and humoral immunogenicity of ChAdOx1 nCoV-19 as a fourth dose booster in individuals who have had two initial doses of the vaccine and a third dose of BNT162b2.
Oladunjoye, Iyiola, Bibi, Sagida, Aley, Parvinder K, Plested, Emma, Robinson, Hannah, Lambe, Teresa, Mujadidi, Yama, Aley, Parvinder K., Pollard, Andrew J, Voysey, Merryn, Faust, Saul N, Faust, Saul N., Ebrahimi, Narges, Felle, Sally, Eordogh, Agnes, Conlin, Kerry, Owino, Nelly, Clutterbuck, Elizabeth A., Gill, Hardeep, Stuart, Arabella, Cappuccini, Federica, Clutterbuck, Elizabeth A, Feng, Shuo, Pollard, Andrew J., Green, Justin, et al.   +25 more
core   +1 more source

Immunogenicity and safety of heterologous versus homologous prime-boost schedules with inactivated and adenoviral vectored SARS-CoV-2 vaccines – A prospective multi-center study

Heliyon
Background: During the peak of Coronavirus disease (COVID-19) pandemic in Thailand when the emergence of delta variant reduced the efficacy of inactivated vaccine, Thailand had abundance of inactivated vaccine but mRNA vaccine was not available and the ...
Pawat Phuensan, Jarongkorn Sirimongkolkasem, Terapong Tantawichien, Jeerath Phannajit, Stephen J. Kerr, Pokrath Hansasuta, Prawat Chantharit, Adisorn Wongsa, Pusit Fuengfoo, Anutra Chittinandana, Kriengsak Vareesangthip, Methee Chayakulkeeree, Sureeporn Jangsirikul, Araya Schmidt, Kanyika Wanvimonsuk, Poramed Winichakoon, Rattagan Kajeekul, Wichai Prayoonwiwat, Rungsun Rerknimitr   +18 more
doaj   +1 more source

Stevens-Johnson syndrome after ChAdOx1 nCoV-19 vaccine

Indian Journal of Dermatology, Venereology and Leprology, 2022
Pedro Alves, da Cruz Gouveia, Larissa N F, Cavalcanti, Lucas C F, Alves, Daniel M, Almeida, Lucília Willa A, Barretto   +4 more
openaire   +2 more sources

Hemophagocytic lymphohistiocytosis following ChAdOx1 nCov‐19 vaccination [PDF]

Journal of Medical Virology, 2021
Sylvia Ai, Alexander Awford, Fernando Roncolato   +2 more
openaire   +1 more source